AVEO Pharmaceuticals Inc logo

AVEO Pharmaceuticals Inc

$ 14.95 +0.08 (+0.54%) 10:08 PM EST
P/E:
At Loss
P/B:
18.01
Market Cap:
$ 519.71M
Enterprise V:
$ 478.21M
Volume:
1.20M
Avg Vol (2M):
1.65M
Also Trade In:
Volume:
1.20M
Market Cap $:
519.71M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.65M
Enterprise Value $:
478.21M
PB Ratio:
18.01
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth factor receptor, or VEGFR, tyrosine kinase inhibitor, or TKI. The group primarily operates in the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 2
Equity-to-Asset 0.29
Debt-to-Equity 1.34
Debt-to-EBITDA -1.59
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.52
Distress
Grey
Safe
Beneish M-Score -0.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 85.6
9-Day RSI 83.08
14-Day RSI 82.76
6-1 Month Momentum % 262.9
12-1 Month Momentum % 134.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.37
Quick Ratio 2.35
Cash Ratio 1.82
Days Inventory 44.63
Days Sales Outstanding 50.35
Days Payable 122.52

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.7

Financials (Next Earnings Date:2023-03-14 Est.)

AVEO's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:AVEO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 94.319
EPS (TTM) ($) -0.84
Beta 1.26
Volatility % 121.75
14-Day RSI 82.76
14-Day ATR ($) 0.140937
20-Day SMA ($) 14.8295
12-1 Month Momentum % 134.82
52-Week Range ($) 3.06 - 14.95
Shares Outstanding (Mil) 34.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AVEO Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

AVEO Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.